Mass spectrometry once again wields its might, combating the COVID-19 pandemic from multiple aspects. Here is a brief look at some of the method development and collaborative efforts that are leading the charge.
The purely digital “reboot” format for the conference this year made for an outstanding experience, rich with interactive, on-demand, and downloadable content -- in addition to some electrifying new product buzz.
Research into SARS-CoV-2 spike protein and other areas are contributing to the development of viable vaccines, drugs, and therapeutic antibodies -- all benefiting from new glycan analysis and LC-MS solutions.
Is Your Chromatography Data System Still State-of-the-Art? Upgrade to the Chromeleon 7 CDS platform, safe in the knowledge that your state of the art CDS is future proofed and ready to quickly adopt regulatory and market changes, while access to your existing Chromeleon 6 CDS data is securely maintained.